The British pharmaceuticals group SHIRE PHARMACEUTICALS (turnover of 1.363 billion dollars in 2004) has acquired the American company TRANSKARYOTIC THERAPIES for 1.6 billion dollars. The operation, which was finalised in the summer, will be paid for in cash at 37 dollars a share.